Argent Biopharma Limited has released a press release.
MXCs 2019 Pharma Commercialisation Strategy
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- Independent Validation of MXC High-Grade Cannabis Genetics
- MXC Botanical Update
- Completion of MGC Derma Sale to CannaGlobal
- Major Regulatory Milestones Achieved for Pharma Business
- First CannEpil Product arrives in Australia
Later from Argent Biopharma
- Received CannEpil Purchase Orders and Import Permit for UK
- Agreement for CBD Nutraceuticals Entry into China Market
- New Distribution Agreements Signed for CannEpil & IMPs
- UK Distribution Agreement with Grow Biotech and IPS
- Arrival of First CannEpil Shipment to United Kingdom
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma